|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||||||
|
||||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=s90269DD8-5ACD-11EF-A798-23D484CE164B&I=39IZM&T=&OP=Display&O=html&O1=15186723&O2=991042752812158&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DAACE%252FACE%2520Disease%2520State%2520Clinical%2520Review%253A%2520Dopamine%2520Agonists%2520for%2520Hyperprolactinemia%2520and%2520the%2520Risk%2520of%2520Cardiac%2520Valve%2520Disease%26rft.au%3DEzzat%252C%2520Shereen%26rft.au%3DSamson%252C%2520Susan%2520L%26rft.date%3D2014-06-01%26rft.eissn%3D1934-2403%26rft.externalDocID%3D24969114%26rft.genre%3Darticle%26rft.issn%3D1530-891X%26rft.issue%3D6%26rft.jtitle%3DEndocrine%2520practice%26rft.spage%3D608%26rft.volume%3D20%26rft_id%3Dinfo%253Adoi%252F10.4158%252FEP14148.RA%26rft_id%3Dinfo%253Apmid%252F24969114%26rft_id%3Dinfo%253Apmid%252F24969114%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-PROQUEST_CENTRAL-getFullTxt-object,2-DOI-getDOI-object,3-COBIB_SI_LCL-getHolding-object,4-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,5-ISI_JOURNAL_CITATION_REPORTS_SCIENCE_EDITION-getCitedJournal-object,6-REFWORKS_EXPORT_TOOL-getReference-object,7-NCBI_PUBMED_FREE-getCitedRecord-object,8-GOOGLE_SCHOLAR_FREE-getWebSearch-object,9-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=2.37676&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:15186723-s90269DD8-5ACD-11EF-A798-23D484CE164B" timestamp="2024-08-15T08:14:01Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:991042752812158</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>AACE/ACE Disease State Clinical Review: Dopamine Agonists for Hyperprolactinemia and the Risk of Cardiac Valve Disease</jnl:atitle>
<jnl:jtitle>Endocrine Practice</jnl:jtitle>
<jnl:date>2014-06-00</jnl:date>
<jnl:spage>608</jnl:spage>
<jnl:epage>616</jnl:epage>
<jnl:coden>EPNRAT</jnl:coden>
<jnl:issn>1530-891X</jnl:issn>
<jnl:volume>20</jnl:volume>
<jnl:issue>6</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>1934-2403</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:coden>EPNRAT</jnl:coden>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:4788e8d15d3ffaa15cecfdd381814c23f6812eb3</ctx:identifier>
<ctx:identifier>urn:UUID:s90269DD8-5ACD-11EF-A798-23D484CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)